Trial Profile
Telmisartan vs valsartan in patients with essential hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2012
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Valsartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 17 May 2012 New trial record
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.